Sarcome

TITRE	Une étude comparant deux types de pansements utilisés après la chirurgie pour les patients atteints de sarcomes des membres inférieurs qui ont été traités par irradiation
PROTOCOLE ID	20170154
CLINICAL TRIAL.gov ID	NCT03175718
TYPE(S) DE CANCER	Sarcome
PHASE	Autres
TYPE D'ÉTUDE	Traitement
INSTITUTION	CENTRE UNIVERSITAIRE DE SANTE MCGILL 1001 boul. Décarie
VILLE	Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E)	Robert Turcotte
COORDONATEUR(RICE)	Mireille Dessureault mireille.dessureault@muhc.mcgill.ca 514-934-1934 poste 43022
STATUT	Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ	(EN) Patients 18 years of age and older and are able to provide written consent. Patients with lower extremity soft tissue sarcoma confirmed by tissue pathology.Each patient must have local cross sectional imaging (CT or MRI) and a staging CT chest. Patients eligible for treatment with preoperative radiation therapy followed by limb salvage surgery. Patients for which a primary closure must be attained at the time of surgery. Patient must be available for postoperative follow-up at the treating center.
CRITÈRES D'EXCLUSION	(EN) Patients who are less than 18 years of age. Patients with a benign disease or who have had previous surgery or radiation therapy to the affected area. Patients who underwent surgical amputation Patients in which primary closure was not achieved (including free flaps and split thickness skin grafts). Patients with a life expectancy less than 120 days. Patients who have an allergy or sensitivity to adhesive dressings. Other major medical condition preventing safe usage of the INPWT dressing.